INS and diabetes mellitus: Previous records indicated the therapeutic effects of coumarins and their derivatives on diabetes; fraxetin significantly decreased BGL as well as glycosylated hemoglobin and increased the plasma insulin level at a dose of 80 mg/kg body weight [36] and octanoyllomatin exhibited a prominent α-glucosidase inhibition with IC50 value (69 μg/mL) [37].